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Background and purpose   Pigmented villonodular synovitis 
(PVNS) is a rare proliferative disorder involving synovial mem-
branes, and patients with PVNS have a variable prognosis. We 
retrospectively analyzed clinical outcomes after synovectomy plus 
low-dose external beam radiotherapy for diffuse PVNS of the 
knee.
Methods   We reviewed the medical records of 23 patients who 
underwent postoperative radiotherapy between 1998 and 2007. 
19 patients had primary disease and 4 had recurrent disease 
with an average of 2.5 prior surgeries. After synovectomy (17 
arthroscopic surgeries; 6 open), all 23 patients received 4-MV 
or 6-MV external beam radiotherapy with a median dose of 20 
(12–34) Gy in 10 fractions. 
Results   At a median follow-up of 9 (0.8–12) years, 4 patients had 
recurrent disease, with a median disease-free interval of 5 years. 
Of these 4 patients, 3 received salvage synovectomy and regained 
local control. Univariate analysis showed that age, sex, history of 
trauma, and total dose of radiation were not predictive of local 
control. 22 patients reported excellent or good joint function, and 
1 who refused salvage synovectomy had poor joint function. None 
of the patients experienced grade 3 or higher radiation-related 
toxicity or radiation-induced secondary malignancies.
Interpretation   Postoperative external beam radiotherapy is 
an effective and acceptable modality to prevent local recurrence 
and preserve joint function in patients with diffuse PVNS of the 
knee. Low-dose (20 Gy) radiotherapy appears to be as effective as 
moderate-dose treatment (around 35 Gy).

Pigmented villonodular synovitis (PVNS) is a rare prolifera-
tive and destructive disorder involving the synovium of joint 
capsules, tendon sheaths, and bursae. The estimated annual 
incidence of PVNS is 1.8 patients per million individuals, and 
young and middle-aged adults are the most frequently affected 
(Myers and Masi 1980). PVNS is usually a monoarticular con-
dition, the predominant site being the knee followed by the 
hip and ankle (Granowitz et al. 1976). The etiology and patho-
genesis of PVNS are unknown, but it may be due to chronic 
inflammation (Oehler et al. 2000) or a neoplastic process 
(Choong et al. 1995, Somerhausen and Fletcher 2000).
There are two distinct forms of PVNS, localized and dif-
fuse, based on the extent of synovial involvement (Granow-
itz et al. 1976, Myers and Masi 1980). The two forms are 
histologically similar, but diffuse PVNS presents with more 
pronounced symptoms and is more rapidly destructive with a 
tendency to invade extra-articular structures such as muscles, 
tendons, bones, neurovascular structures, and skin (Granow-
itz et al. 1976, O’Sullivan et al. 1995). Whereas successful 
local control can be achieved by excision of localized masses 
(Granowitz et al. 1976, Rao and Vigorita 1984), complete 
tumor removal in patients with the diffuse form may be more 
difficult, with recurrence rates after surgery alone ranging 
from 8% to 56% depending on the extent of surgery (Schwartz 
et al. 1989, Ogilvie-Harris et al. 1992, Flandry et al. 1994, 
Zvijac et al. 1999). Postoperative radiotherapy (RT) has been 
used to achieve better local control in patients with primary or 
recurrent PVNS (O’Sullivan et al. 1995, Blanco et al. 2001, 
Chin et a. 2002, Lee et al. 2005, Berger et al. 2007, Horoschak 
et al. 2009, Heyd et al. 2010). 
It is unclear whether treatment outcomes are influenced by 
the location of the disease or the radiation dose. PVNS of the 
knee is, however, associated with a higher recurrence rate than 
PVNS at other joints (Schwartz et al. 1989). Moreover, there 
have been no studies on radiation dose-response relationships 
to date. At Asan Medical Center, patients have been given Acta Orthopaedica 2012; 83 (3): 256–260  257
the conventional dose (32–34 Gy) or a lower dose (20 Gy) as 
postoperative treatment for diffuse PVNS of the knee, depend-
ing on the views of treating physicians who favored different 
pathogenesis theories—neoplasia or chronic inflammation. 
We retrospectively compared the clinical outcomes of patients 
who were treated with conventional or low-dose RT. 
Patients and methods 
Patient characteristics
We retrospectively reviewed the medical records of 23 con-
secutive patients who received external beam RT after syn-
ovectomy for diffuse PVNS of the knee at Asan Medical 
Center between 1998 and 2007 (Table 1). The diagnosis in all 
patients was confirmed histopathologically. Median age was 
37 (10–64) years and 15 patients were female. Pain and swell-
ing of the affected knee were the predominant symptoms, 
with median duration of symptoms of 1.5 (0.5–10) years. 4 
patients received postoperative RT for recurrent disease, with 
2–3 prior surgeries. MRI was performed in all patients at the 
initial diagnosis, and at follow-up in 15 patients.
Treatment characteristics 
17 patients underwent arthroscopic synovectomy and the other 
6 underwent open synovectomy (Table 1). After cytoreductive 
surgery, 13 patients had obvious gross residual disease and 
2 had suspected residual lesions. The remaining 8 patients, 
with no macroscopic tumor tissue left after surgery, received 
adjuvant RT. Patients were given postoperative RT if they had 
(1) large extra-articular and/or infiltrative disease (n = 10), (2) 
extensive local recurrences (n = 4), or  (3) limited access to the 
affected joint during arthroscopic surgery (n = 9). 
The median interval from the surgical procedure to the com-
mencement of RT was 28 (18–48) days. All patients under-
went RT using 4-MV or 6-MV photons with linear accelera-
tors through two opposing fields (anterior to posterior and 
posterior to anterior) at a dose of 2 Gy per fraction once a 
day. Of the 23 patients, 13 (cases 1–13) were scheduled to 
receive 20 Gy by one physician and the other 10 were sched-
uled to receive 32–34 Gy by the other physician. 2 patients in 
each group (cases 1, 11, 14, and 21) refused to complete their 
planned radiotherapy. In four patients, a computed tomog-
raphy-based 3-dimensional treatment planning system was 
used. Clinical target volume was defined as the tumor bed plus 
5 cm margins superoinferiorly and the entire synovial cavity 
of the affected knee based on preoperative MRI and/or opera-
Table 1. Patient and treatment characteristics
 A  B  C  D  E  F  G  H  I  J  K  L  M
 1  28  M  No  P  A  R0  16  No      9  Good
 2  48  M  No  P  A  R0  20  No      141  Good
  3 14 M Yes P  A  R0  20  No      140  Excellent
 4  25  F  No  P  A  R2  20  No      140  Good
 5  10  F  Yes  P  A  R2  20  Yes  43  Yes  136  Excellent
 6  41  F  No  P  O  R2  20  Yes  62  Yes  130  Excellent
 7  31  F  No  P  A  R2  20  No      118  Good
 8  45  F  No  P  A  R0  20  No      115  Good
 9  41  F  Yes  P  A  R2  20  No      115  Good
 10  43  F  No  Re  A  R2  20  No      114  Good
 11  50  F  Yes  P  A  R0  12  No      109  Good
 12  64  F  No  P  A  R1  20  No      106  Excellent
 13  53  F  Yes  P  O  R2  20  No      105  Excellent
 14  28  F  Yes  P  O  R1  26  No      97  Excellent
 15  49  M  No  P  O  R0  34  No      91  Excellent
 16  22  M  No  Re  A  R2  32  No      89  Excellent
 17  37  F  No  P  A  R2  32  No      89  Good
 18  27  F  No  Re  A  R2  34  Yes  63  Refused  87  Poor
 19  22  M  No  Re  O  R2  34  Yes  62  Yes  84  Good
 20  31  F  No  P  O  R2  34  No      83  Excellent
 21  45  M  No  P  A  R0  26  No      82  Excellent
 22  34  F  Yes  P  A  R2  34  No      69  Excellent




D History of trauma 
E  Primary (P) vs. recurrent (Re) 
F  Surgery method
  A: Arthroscopic
  O: Open 
G Resection status
  R0: No residual disease
  R1: Suspicion of residual disease
  R2: Gross residual disease
H Dose (Gy) 
I Recurrence
J  Disease-free interval (m) 
K  Salvage surgery 
L  Follow-up period (m) 
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tion records. The planning target volume was defined from the 
clinical target volume with a margin of 10 mm. 
Follow-up evaluation and statistical analysis
Following RT, patients were routinely followed up by physi-
cal examination, with an MRI performed if symptoms became 
aggravated. Local recurrence was defined as new or increasing 
synovial lesions based on either MRI or pathological findings 
during salvage operations. The functional status of the involved 
joint was assessed as described previously (O’Sullivan et al. 
1995, Berger et al. 2007): excellent (no symptoms), good 
(minor symptoms), fair (moderate symptoms or joint dys-
function that did not interfere with daily activities), and poor 
(severe symptoms that interfered with daily activities). Com-
plications of RT were recorded using the Common Terminol-
ogy Criteria for Adverse Events (CTCAE) version 4.0.
The baseline follow-up date was the start of RT and the last 
follow-up date was the last hospital visit or date of telephone 
conversation. Local control was calculated from the baseline 
date to the date of first recurrence or last follow-up. Univari-
ate analyses were performed to examine the effect on local 
control of age, sex, history of trauma, primary vs. recurrent 
disease, number of prior surgeries, and radiation dose (≤ 20 
Gy vs. > 20 Gy). All p-values were two-sided, and p-values 
< 0.05 were considered statistically significant. SPSS software 
version 12.0K was used for all statistical analyses.
Results
At a median follow-up time of 9 (0.8–12) years, 19 of the 23 
patients showed no evidence of recurrence or persistent dis-
ease. 4 patients had local recurrences. 2 had received 20 Gy of 
external-beam RT and the others had received 34 Gy. Of these 
4 patients, 3 regained local control after salvage synovectomy, 
whereas the remaining patient refused further surgery. The 
time interval between RT and diagnosis of recurrence was 
longer than 5 years in 3 of the 4 patients. Univariate analysis 
showed that age (≤ 37 vs. > 37 years, p = 0.6), gender (p = 
1), trauma history (p = 1), primary vs. recurrent (p = 0.1), 
number of prior surgeries (≤ 2 vs. > 2, p = 0.3), and total dose 
of RT (≤ 20 Gy vs. > 20 Gy, p = 1) were not associated with 
rate of local control. Patient and treatment characteristics were 
similar in the low-dose group and the conventional-dose group 
(≤ 20 Gy vs. > 20 Gy) (Table 2).
Of the 23 patients, 6 reported excellent joint function and 16 
reported good joint function, whereas the patient who refused 
salvage synovectomy reported poor joint function. None of 
these patients, including the 3 who underwent salvage syno-
vectomy after RT, experienced radiation-related early or late 
complications greater than grade 2. None developed any radi-
ation-induced malignancy.
Discussion
Local control was achieved in 19 of the 23 patients who under-
went cytoreductive surgery followed by RT, with excellent or 
good joint function in all but 1 patient. Our findings are similar 
to those in previous reports (O’Sullivan et al. 1995, Blanco et 
al. 2001, Chin et al. 2002, Berger et al. 2007, Horoschak et al. 
2009, Heyd et al. 2010) (Table 3). 
There are several distinguishing aspects of our analysis. 
First, the follow-up time (median 9 years) was far longer than 
in most other studies. Long follow-up is required to detect local 
recurrence. For example, the average time to local recurrence 
in 4 patients (Horoschak et al. 2009) was 3 years, and local 
recurrences have been reported as long as 17 years after pri-
mary treatment (Panagiotopoulos et al. 1993). In our study, the 
4 patients with recurrent disease had a median time to failure 
of 5 years, with 3 having disease-free intervals of longer than 5 
years. Secondly, the median total dose of postoperative RT in 
our patients was 20 Gy, which was much lower than in other 
studies (O’Sullivan et al. 1995, Blanco et al. 2001, Chin et al. 
2002, Lee et al. 2005, Berger et al. 2007, Horoschak et al. 2009, 
Heyd et al. 2010). The doses as low as 20 Gy in 10 fractions 
came from the general prescribed doses for benign diseases 
such as thyroid ophthalmopathy (Petersen et al. 1990), orbital 
pseudotumor (Lanciano et al. 1990), and heterotopic ossifica-
tion (MacLennan et al. 1984). Treatment of PVNS with total 
doses of < 30 Gy has been associated with recurrence rates 
of 4–14% after median 3.5 years of follow-up (Ustinova et al. 
1986, Kotwal et al. 2000, Blanco et al. 2001). Although other 
studies have used doses of 30–50 Gy (O’Sullivan et al. 1995, 
Berger et al. 2007, Heyd et al. 2010), there have been no stud-
ies showing dose-response relationships for postoperative RT 
in patients with PVNS. A recent study examining the correla-
tion between total dose and local control in 41 patients from 14 
departments failed to show a significant dose-effect relationship 
(Heyd et al. 2010). Of the 4 patients in our study who experi-
enced recurrences, 2 had received 20 Gy RT whereas the other 
Table 2. Patient and treatment characteristics by radiation dose 
group
Variables  ≤ 20 Gy  > 20 Gy  p-value
  (n = 13)  (n = 10)
Mean age, years  38  35  0.6
Male : Female  3:10  5:5  0.2
History of trauma (yes : no)  5:8  2:8  0.4
Primary : Recurrent  12:1  7:3  0.3
Synovectomy method
  (open : arthroscopic)  2:11  4:6  0.3
Resection status (R0 : R1 : R2) a 5:1:7  3:1:6  0.9
Recurrence (yes : no)   2:11  2:8  0.6
7-year recurrence-free survival  83%  78%  0.8
Final joint function
  (excellent : good : poor)  5:8:0  7:2:1  0.1
 a Resection status: See Table 1 (G)Acta Orthopaedica 2012; 83 (3): 256–260  259
2 had received 34 Gy, which indicates the same local control 
rate for the two treatment regimens. Thirdly, only patients with 
PNVS of the knee joint were included in our analysis. Despite 
the inconclusive relationship between location of PVNS and 
local control rate, local recurrence of PVNS of the knee has 
been reported more frequently than recurrences at other joints 
(Schwartz et al. 1989). 
We found similar local control rates in patients with primary 
PVNS and those with recurrent PVNS. Likewise, the number 
of previous surgeries had no effect on local control and func-
tional outcomes. These findings are in accordance with those 
from a study of 24 patients with primary PVNS and 17 patients 
with recurrent PVNS (Heyd et al. 2010). Use of RT for benign 
disease such as PVNS may introduce concerns about the risks 
of functional impairment and radiation-induced malignancy. 
Of our patients, all but 1 showed excellent or good joint func-
tion. Similarly to other small-sized series, we did not observe 
any severe early or late radiation-related complications or sec-
ondary malignancies. To our knowledge, there have been no 
reports to date of radiation-induced malignancy after RT for 
PVNS. 
The limitations of our study were its retrospective design, 
which may have introduced selection bias, and the small 
number of patients. Due to the low incidence of PVNS, it is 
almost impossible to perform large-scale prospective stud-
ies. To our knowledge, our study is the largest one so far of 
patients at a single center who received RT with modern tech-
nique for diffuse PVNS of the knee, and showing good local 
control. 
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